Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication November 23, 2021
- Revision received February 17, 2022
- Published online September 1, 2022.
Article Versions
- previous version (February 24, 2022 - 13:13).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2022 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
- Johanna Diekmann*,1,
- Tobias Koenig*,2,
- James T. Thackeray1,
- Thorsten Derlin1,
- Christoph Czerner1,2,
- Jonas Neuser2,
- Tobias L. Ross1,
- Andreas Schäfer2,
- Jochen Tillmanns2,
- Johann Bauersachs*,2 and
- Frank M. Bengel*,1
- 1Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany; and
- 2Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany
- For correspondence or reprints, contact Frank M. Bengel (bengel.frank{at}mh-hannover.de) or Johanna Diekmann (diekmann.johanna{at}mh-hannover.de).
↵* Contributed equally to this work.
Statistics from Altmetric.com
Cited By...
Article usage
In this issue
Jump to section
Related Articles
Cited By...
- SNMMI Procedure Standard/EANM Practice Guideline for Fibroblast Activation Protein (FAP) PET
- Nuclear Cardiology Surrogate Biomarkers in Clinical Trials
- 1,090 Publications and 5 Years Later: Is FAP-Targeted Theranostics Really Happening?
- Toward Quantitative Multisite Preclinical Imaging Studies in Acute Myocardial Infarction: Evaluation of the Immune-Fibrosis Axis
- Molecular Imaging Biomarkers in Cardiooncology: A View on Established Technologies and Future Perspectives
- Myocardial Fibrosis: Emerging Target for Cardiac Molecular Imaging and Opportunity for Image-Guided Therapy
- Molecular Imaging of Myocardial Fibroblast Activation in Patients with Advanced Aortic Stenosis Before Transcatheter Aortic Valve Replacement: A Pilot Study
- Molecular Imaging of Myocardial Fibroblast Activation in Patients with Advanced Aortic Stenosis Before Transcatheter Aortic Valve Replacement: A Pilot Study
- Fibroblast Activation Protein Inhibitor Imaging in Nonmalignant Diseases: A New Perspective for Molecular Imaging